Joseph P. Lyssikatos

CHIEF SCIENTIFIC OFFICER

CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc., filing insider transactions on 2026-02-06.

Total Purchases

—

0 transactions

Total Sales

$145K

1 transaction

Companies Traded

1 total filings

Active Since

2026-02-06

Last: 2026-02-06

Companies

Enliven Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-06	ELVN	Sale	5,000	$29.04	$145K	740.2K	SEC ↗